Table 2 Cumulative Clinical Events.
Events | Cordimax (n = 2460) | Xience V (n = 1237) | RR (95% CI) | P value |
|---|---|---|---|---|
Events at 6 month | ||||
TLF | 4 (0.2%) | 4 (0.3%) | 0.50 (0.13–2.01) | 0.32 |
All cause death | 0 (0%) | 1 (0.1%) | — | — |
Cardiac death | 0 (0%) | 1 (0.1%) | — | — |
MI | 0 (0%) | 0 (0%) | — | — |
TLR (clinically driven) | 4 (0.2%) | 3 (0.2%) | 0.67 (0.15–2.99) | 0.60 |
Death or MI | 0 (0%) | 1 (0.1%) | — | — |
MACE | 4 (0.2%) | 4 (0.3%) | 0.50 (0.13–2.01) | 0.32 |
Events at 1 year | ||||
TLF | 86 (3.5%) | 40 (3.2%) | 1.07 (0.74–1.55) | 0.73 |
All cause death | 7 (0.3%) | 4 (0.3%) | 0.88 (0.26–3.00) | 0.84 |
Cardiac death | 6 (0.2%) | 3 (0.2%) | 1.01 (0.25–4.01) | 0.99 |
MI | 27 (1.1%) | 8 (0.6%) | 1.70 (0.77–3.72) | 0.18 |
TLR (clinically driven) | 57 (2.3%) | 28 (2.3%) | 1.02 (0.66–1.60) | 0.92 |
Death or MI | 34 (1.4%) | 12 (1.0%) | 1.43 (0.74–2.74) | 0.29 |
MACE | 86 (3.5%) | 40 (3.2%) | 1.08 (0.75–1.56) | 0.68 |
Events at 2 year | ||||
TLF | 113 (4.6%) | 61 (4.9%) | 0.93 (0.69–1.26) | 0.65 |
All cause death | 7 (0.3%) | 6 (0.5%) | 0.59 (0.20–1.74) | 0.33 |
Cardiac death | 6 (0.2%) | 3 (0.2%) | 1.01 (0.25–4.01) | 0.99 |
MI | 30 (1.2%) | 9 (0.7%) | 1.68 (0.80–3.52) | 0.17 |
TLR (clinically driven) | 82 (3.3%) | 49 (4.0%) | 0.84 (0.60–1.19) | 0.33 |
Death or MI | 37 (1.5%) | 115 (1.2%) | 1.24 (0.68–2.25) | 0.48 |
MACE | 114 (4.6%) | 62 (5.0%) | 0.93 (0.68–1.25) | 0.61 |
Events at 3 year | ||||
TLF | 121 (4.9%) | 78 (6.3%) | 0.78 (0.59–1.03) | 0.08 |
All cause death | 9 (0.4%) | 8 (0.6%) | 0.57 (0.22–1.46) | 0.23 |
Cardiac death | 8 (0.3%) | 5 (0.4%) | 0.81 (0.26–2.45) | 0.70 |
MI | 30 (1.2%) | 11 (0.9%) | 1.37 (0.69–2.73) | 0.37 |
TLR (clinically driven) | 88 (3.6%) | 63 (5.1%) | 0.70 (0.51–0.96) | 0.03 |
Death or MI | 39 (1.6%) | 19 (1.5%) | 1.03 (0.60–1.78) | 0.91 |
MACE | 122 (5.0%) | 79 (6.4%) | 0.78 (0.59–1.02) | 0.07 |
